scholarly journals Characteristics of peripheral Vγ2Vδ2 T cells in interferon-γ release assay negative pulmonary tuberculosis patients

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Liping Yan ◽  
Hongbo Shen ◽  
Heping Xiao
2013 ◽  
Vol 20 (4) ◽  
pp. 530-539 ◽  
Author(s):  
Xueyan Xi ◽  
Xiqin Han ◽  
Liang Li ◽  
Zhendong Zhao

ABSTRACTThe immune protection initiated by γδ T cells plays an important role in mycobacterial infection. The γδ T cells activated byMycobacterium tuberculosis-derived nonpeptidic, phosphorylated biometabolites (phosphoantigens) provide only partial immune protection against mycobacterium, while evidence has suggested that protein antigen-activated γδ T cells elicit effective protective immune responses. To date, only a few distinct mycobacterial protein antigens have been identified. In the present study, we screened protein antigens recognized by γδ T cells using cells transfected with the predominant pulmonary tuberculosis γδ T cell receptor (TCR) CDR3 fragment. We identified two peptides, TP1 and TP2, which not only bind to the pulmonary tuberculosis predominant γδ TCR but also effectively activate γδ T cells isolated from pulmonary tuberculosis patients. Moreover, 1-deoxy-d-xylulose 5-phosphate synthase 2 (DXS2), the TP1-matched mycobacterial protein, was confirmed as a ligand for the γδ TCR and was found to activate γδ T cells from pulmonary tuberculosis patients. The extracellular region (extracellular peptide [EP]) of Rv2272, a TP2-matched mycobacterial transmembrane protein, was also shown to activate γδ T cells from pulmonary tuberculosis patients. Both DXS2- and EP-expanded γδ T cells from pulmonary tuberculosis patients could secrete gamma interferon (IFN-γ) and monocyte chemoattractant protein 1 (MCP-1), which play important roles in mediating cytotoxicity against mycobacterium and stimulating monocyte chemotaxis toward the site of infection. In conclusion, our study identified novel mycobacterial protein antigens recognized by γδ TCR cells that could be candidates for the development of vaccines or adjuvants against mycobacterium infection.


2014 ◽  
Vol 55 (3) ◽  
pp. 725 ◽  
Author(s):  
HeeJin Park ◽  
Jung Ar Shin ◽  
Hyung Jung Kim ◽  
Chul Min Ahn ◽  
Yoon Soo Chang

1995 ◽  
Vol 42 (6) ◽  
pp. 823
Author(s):  
Gyeong Ryeol Ryu ◽  
Chong Hwa Park ◽  
Une Sook Park ◽  
Pan Joon Jeoung ◽  
Young Sil Hwang ◽  
...  

Tuberculosis ◽  
2016 ◽  
Vol 100 ◽  
pp. 61-68 ◽  
Author(s):  
Martha Zewdie ◽  
Rawleigh Howe ◽  
Søren T. Hoff ◽  
T. Mark Doherty ◽  
Nahom Getachew ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Jiayue Rao ◽  
Rigu Su ◽  
Yiping Peng ◽  
Yang Guo ◽  
Zikun Huang ◽  
...  

BackgroundT-SPOT TB (T-SPOT) assay is widely used for detection of Mycobacterium tuberculosis infection that is based on the detection of M. tuberculosis-specific interferon-γ-secreting T cells (ISCs) in peripheral blood mononuclear cells (PBMCs). Recently, high frequencies of low-density granulocytes (LDGs) were found in the PBMCs of tuberculosis patients. Whether these LDGs affect the detection of T-SPOT has not been investigated. The impact of LDGs on T-SPOT assay and related mechanism were investigated in this study.MethodsThe correlations between the frequencies of LDGs and the results of T-SPOT were analyzed. T-SPOT with LDG-removed PBMCs and PBMCs with exogenous addition of LDGs were performed. The possible mechanism was explored by detecting the levels of negative immune regulatory molecules on LDGs. The impact of programmed death ligand 1 (PD-L1) on T-SPOT was evaluated and confirmed by function blocking with neutralizing antibody.ResultsThe positive rates of T-SPOT and ISCs in tuberculosis patients with low LDGs frequency (n = 22) were significantly higher than those with high LDGs frequency (n = 39). Removal or exogenous addition of LDGs significantly increased or decreased the ISCs and the positive rate of T-SPOT. The frequencies of interferon-γ-producing T cells were negatively correlated with the frequencies of LDGs. The expression of PD-L1 was significantly elevated on LDGs. Pretreatment of LDGs with anti-PD-L1 antibody significantly counteracted the impact of LDGs on T-SPOT. Treatment of PBMCs with anti-PD-L1 antibody resulted in comparable ISCs with that of LDG removal.ConclusionLDGs can inhibit the production of interferon-γ in T cells and decrease the positive rated of T-SPOT assay via highly expressed PD-L1.


Sign in / Sign up

Export Citation Format

Share Document